NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球次世代定序的市場預測、競爭趨勢、成長機會 (∼2025年):各產品、技術、終端用戶、用途、地區

Global Next-generation Sequencing Market, By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 974942
出版日期 內容資訊 英文 153 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球次世代定序的市場預測、競爭趨勢、成長機會 (∼2025年):各產品、技術、終端用戶、用途、地區 Global Next-generation Sequencing Market, By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年12月01日內容資訊: 英文 153 Pages
簡介

全球次世代定序的市場規模從2019年的82億675萬美元,預計在預測期間中19.59%的年複合成長率成長。以次世代定序為基礎的診斷檢驗相關法規的強化,次世代定序的進步和NGS平台的價格低等要素預計促進該市場成長。同時,NGS為基礎的診斷法的標準化相關疑慮有妨礙市場進一步成長的可能性。

本報告提供全球次世代定序的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,世界及各地區、國家的市場規模及市場佔有率的變化、預測,產品、技術、終端用戶、用途等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 產品概要

第2章 調查手法

第3章 COVID-19的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球市場的展望

  • 市場規模、預測
  • 市場佔有率、預測
  • 各產品
    • 消耗品
    • 平台
    • 服務
  • 各技術
    • 合成定序
    • 離子半導體定序
    • 連接測序
    • 單一分子即時定序等
  • 各終端用戶
    • 學術、臨床研究中心
    • 製藥、生物科技企業
    • 醫院、診療所等
  • 各用途
    • 生物標記、癌症
    • 診斷
    • 生殖健康
    • 個人化醫療
    • 農業、動物研究等
  • 各地區
  • 各企業
  • 產品市場地圖

第7章 北美市場展望

  • 市場規模、預測
  • 市場佔有率、預測
  • 各產品
  • 各技術
  • 各終端用戶
  • 各用途
  • 各國

第8章 歐洲市場展望

  • 市場規模、預測
  • 市場佔有率、預測
  • 各產品
  • 各技術
  • 各終端用戶
  • 各用途
  • 各國

第9章 亞太地區市場展望

  • 市場規模、預測
  • 市場佔有率、預測
  • 各產品
  • 各技術
  • 各終端用戶
  • 各用途
  • 各國

第10章 中東、非洲市場展望

  • 市場規模、預測
  • 市場佔有率、預測
  • 各產品
  • 各技術
  • 各終端用戶
  • 各用途
  • 各國

第11章 南美市場展望

  • 市場規模、預測
  • 市場佔有率、預測
  • 各產品
  • 各技術
  • 各終端用戶
  • 各用途
  • 各國

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭預測
  • 企業簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • BGI Group
    • Perkinelmer Inc.
    • Agilent Technologies, Inc.
    • Pacific Biosciences of California Inc.
    • F. Hoffmann-La Roche Ltd.
    • 10x Genomics Inc.
    • Amgen Inc.
    • Takara Bio Inc.

第15章 策略性建議

第16章 關於本公司、免責聲明

目錄
Product Code: 4508

Title:
Global Next-generation Sequencing Market, By Product (Consumables, Platforms and Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Other Applications), By Region, Competition, Forecast & Opportunities, 2025.

Global next-generation sequencing market was valued at USD 8206.75 Million in 2019 and is projected to grow at a CAGR of 19.59% during the forecast period. Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of global next-generation sequencing market during the forecast period. Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of global next-generation sequencing market over the coming years. However, some of the factors that might act as major impediments to the growth of global next-generation sequencing market includes concerns pertaining to the standards of NGS based diagnostics.

The global next-generation sequencing market is segmented based on product, technology, end user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing and other technologies. Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 with share of 73.04% and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina's systems as it uses the SBS technology.

Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Perkinelmer Inc., Agilent Technologies, Inc., Pacific Biosciences of California Inc., F. Hoffmann-La Roche Ltd., 10x Genomics Inc., Amgen Inc., Takara Bio Inc. and others.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyse and forecast the market size of global next-generation sequencing market.
  • To classify and forecast global next-generation sequencing market based on product, technology, end user, application, company and regional distribution.
  • To identify drivers and challenges for global next-generation sequencing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global next-generation sequencing market.
  • To conduct pricing analysis for global next-generation sequencing market.
  • To identify and analyse the profile of leading players operating in global next-generation sequencing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed new services, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global next-generation sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Next-generation sequencing service providers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to next-generation sequencing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global next-generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product:

  • Consumables
  • Platforms
  • Services

Market, By Technology:

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Single Molecule Real Time Sequencing
  • Other Technologies

Market, By End User:

  • Academic & Clinical Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Others

Market, By Application:

  • Biomarkers & Cancer
  • Diagnostics
  • Reproductive Health
  • Personalized Medicine
  • Agriculture & Animal Research
  • Other Applications

Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global next-generation sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Next-Generation Sequencing (NGS) Market

4. Executive Summary

5. Voice of Customer

  • 5.1. By Brand Recall
  • 5.2. By Preferred Technology
  • 5.3. By Preferred Application

6. Global Next-Generation Sequencing (NGS) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables, Platforms and Services)
      • 6.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
      • 6.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
      • 6.2.1.3. By Services (Sequencing Services and Data management services)
    • 6.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other)
    • 6.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
    • 6.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2019)
  • 6.3. Product Market Map

7. North America Next-Generation Sequencing (NGS) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Application
    • 7.2.5. By Country (United States; Canada; Mexico and Rest of North America)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Next-Generation Sequencing (NGS) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. Canada Next-Generation Sequencing (NGS) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. Mexico Next-Generation Sequencing (NGS) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application

8. Europe Next-Generation Sequencing (NGS) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Application
    • 8.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. Germany Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. United Kingdom Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. Italy Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Spain Next-Generation Sequencing (NGS) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Asia-Pacific Next-Generation Sequencing (NGS) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Application
    • 9.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. India Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. Japan Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
    • 9.3.4. South Korea Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Technology
        • 9.3.4.2.3. By Application
    • 9.3.5. Australia Next-Generation Sequencing (NGS) Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Technology
        • 9.3.5.2.3. By Application

10. Middle East and Africa Next-Generation Sequencing (NGS) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By End User
    • 10.2.4. By Application
    • 10.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Next-Generation Sequencing (NGS) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Next-Generation Sequencing (NGS) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Next-Generation Sequencing (NGS) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. South America Next-Generation Sequencing (NGS) Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Technology
    • 11.2.3. By End User
    • 11.2.4. By Application
    • 11.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Next-Generation Sequencing (NGS) Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Application
    • 11.3.2. Argentina Next-Generation Sequencing (NGS) Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Application
    • 11.3.3. Colombia Next-Generation Sequencing (NGS) Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Application

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (NGS Platform Providers)

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Illumina, Inc.
    • 14.2.2. Thermo Fisher Scientific, Inc
    • 14.2.3. BGI Group
    • 14.2.4. Perkinelmer Inc.
    • 14.2.5. Agilent Technologies, Inc.
    • 14.2.6. Pacific Biosciences of California Inc.
    • 14.2.7. F. Hoffmann-La Roche Ltd.
    • 14.2.8. 10x Genomics Inc.
    • 14.2.9. Amgen Inc.
    • 14.2.10. Takara Bio Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

(Note: The companies list can be customized based on the client requirements.)

List of Figures

  • Figure 1: Global Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 2: Global Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 3: Global Next-Generation Sequencing Market Share, By Product, By Consumables, By Value, 2015-2025F
  • Figure 4: Global Next-Generation Sequencing Market Share, By Product, By Platforms, By Value, 2015-2025F
  • Figure 5: Global Next-Generation Sequencing Market Share, By Product, By Services, By Value, 2015-2025F
  • Figure 6: Global Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 7: Global Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 8: Global Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 9: Global Next-Generation Sequencing Market Share, By Company, By Value, 2019
  • Figure 10: Global Next-Generation Sequencing Market Share, By Region, By Value, 2019 & 2025F
  • Figure 11: Global Next-Generation Sequencing Market Map, By Product - Market Size (USD Million) & Growth Rate (%)
  • Figure 12:Global Next-Generation Sequencing Market Map, By Technology - Market Size (USD Million) & Growth Rate (%)
  • Figure 13: Global Next-Generation Sequencing Market Map, By End User - Market Size (USD Million) & Growth Rate (%)
  • Figure 14: Global Next-Generation Sequencing Market Map, By Application - Market Size (USD Million) & Growth Rate (%)
  • Figure 15: Global Next-Generation Sequencing Market Map, By Region - Market Size (USD Million) & Growth Rate (%)
  • Figure 16: North America Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 17: North America Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 18: North America Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 19: North America Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 20: North America Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 21: North America Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 22: United States Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 23: Total Human Genome Funding by National Institute for Health (NIH) in United States, USD Million, 2015-2019
  • Figure 24: United States Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 25: United States Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 26: United States Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 27: Canada Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 28: Canada Hospital Establishments, By Region, 2019 (Units)
  • Figure 29: Canada Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 30: Canada Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 31: Canada Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 32: Mexico Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 33: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 34: Mexico Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 35: Mexico Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 36: Mexico Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 37: Europe Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 38: Europe Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 39: Europe Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 40: Europe Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 41: Europe Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 42: Europe Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 43: United Kingdom Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 44: New Cancer Cases in United Kingdom (%), 2019
  • Figure 45: United Kingdom Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 46: United Kingdom Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 47: United Kingdom Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 48: Germany Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 49: New Cancer Cases in Germany (%), Females, All Ages, 2019
  • Figure 50: Germany Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 51: Germany Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 52: Germany Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 53: France Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 54: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
  • Figure 55: France Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 56: France Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 57: France Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 58: Italy Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 59: New Cancer Cases in Italy (%), Males, All Ages, 2019
  • Figure 60: Italy Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 61: Italy Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 62: Italy Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 63: Spain Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 64: Number of New Cancer Cases in Spain, By Cancer Site, 2019
  • Figure 65: Spain Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 66: Spain Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 67: Spain Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 68: Asia-Pacific Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 69: Asia-Pacific Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 70: Asia-Pacific Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 71: Asia-Pacific Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 72: Asia-Pacific Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 73: Asia-Pacific Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 74: China Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 75: New Cancer Cases in China (%), 2019
  • Figure 76: China Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 77: China Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 78: China Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 79: Japan Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 80: Japan Total Health Expenditure as a Share of GDP (%), 2015 - 2019
  • Figure 81: Japan Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 82: Japan Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 83: Japan Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 84: South Korea Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 85: New Cancer Cases in South Korea (%), 2019
  • Figure 86: South Korea Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 87: South Korea Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 88: South Korea Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 89: Australia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 90: % of Public and Private Hospitals in Australia, 2019
  • Figure 91: Australia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 92: Australia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 93: Australia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 94: India Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 95: New Cancer Cases in India (%), Both Sexes, All Ages, 2019
  • Figure 96: India Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 97: India Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 98: India Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 99: South America Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 100: South America Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 101: South America Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 102: South America Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 103: South America Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 104: South America Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 105: Brazil Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 106: Total Number of Hospitals in Brazil, 2015-2018
  • Figure 107: Brazil Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 108: Brazil Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 109: Brazil Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 110: Argentina Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 111: Argentina Health Expenditure (% of GDP), 2015-2019
  • Figure 112: Argentina Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 113: Argentina Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 114: Argentina Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 115: Colombia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 116: New Cancer Cases in Colombia (%), 2019
  • Figure 117: Colombia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 118: Colombia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 119: Colombia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 120: Middle East and Africa Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 121: Middle East and Africa Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 122: Middle East and Africa Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 123: Middle East and Africa Next-Generation Sequencing Market Share, By End User, By Value, 2015-2025F
  • Figure 124: Middle East and Africa Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 125: Middle East and Africa Next-Generation Sequencing Market Share, By Region, By Value, 2015-2025F
  • Figure 126: UAE Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 127: UAE Health Expenditure (% of GDP), 2015-2019
  • Figure 128: UAE Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 129: UAE Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 130: UAE Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 131: Saudi Arabia Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 132: Total Number of Hospitals in Saudi Arabia, 2015-2019
  • Figure 133: Saudi Arabia Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 134: Saudi Arabia Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 135: Saudi Arabia Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F
  • Figure 136: South Africa Next-Generation Sequencing Market Size, By Value, 2015-2025F (USD Million)
  • Figure 137: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
  • Figure 138: South Africa Next-Generation Sequencing Market Share, By Product, By Value, 2015-2025F
  • Figure 139: South Africa Next-Generation Sequencing Market Share, By Technology, By Value, 2015-2025F
  • Figure 140: South Africa Next-Generation Sequencing Market Share, By Application, By Value, 2015-2025F